Pharmanex is a global leader in evidenced and science-based, nutritional supplementation and operates in over 50 markets worldwide. A key differentiator for Pharmanex is their S3 Biophotonic Scanner – the only one in the World! The scanner technology utilizes a Nobel Prize winning discovery by Dr. Raman in the 1920s, which was then developed under an NIH grant at the University of Utah in the late 1990s to detect macular degeneration. Pharmanex bought the patents and technology and have spent close to $150M to create this new S3 scanner. The scanner checks a person’s cellular health by measuring the Skin Carotenoid level which directly relates to their body's antioxidant level. Lack of antioxidants and the effect of free radicals on the body lead to oxidative stress and inflammation which is a mechanism to many/most diseases such as cancer, diabetes, macular degeneration, heart disease, Alzheimer’s, COVID, etc. There are 115+ published technical and peer- reviewed studies and articles that have validated this scanner technology.